BLTE
Price:
$151.27
Market Cap:
$5.28B
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in ...[Read more]
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
BLTE
According to Belite Bio, Inc’s latest financial reports and current stock price. The company's current ROE is -34.90%. This represents a change of 303.63% compared to the average of -8.65% of the last 4 quarters.
The mean historical ROE of Belite Bio, Inc over the last ten years is 11.11%. The current -34.90% ROE has changed -414.07% with respect to the historical average. Over the past ten years (40 quarters), BLTE's ROE was at its highest in in the March 2020 quarter at 60.03%. The ROE was at its lowest in in the September 2022 quarter at -5790.22%.
Average
11.11%
Median
-24.79%
Minimum
-34.98%
Maximum
81.75%
Discovering the peaks and valleys of Belite Bio, Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 14.77%
Maximum Annual ROE = 81.75%
Minimum Annual Increase = -147.59%
Minimum Annual ROE = -34.98%
| Year | ROE | Change |
|---|---|---|
| 2024 | -24.79% | -29.14% |
| 2023 | -34.98% | 14.77% |
| 2022 | -30.48% | -147.59% |
| 2021 | 64.04% | -21.66% |
The current ROE of Belite Bio, Inc (BLTE) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-30.08%
5-year avg
11.11%
10-year avg
11.11%
Belite Bio, Inc’s ROE is greater than Mirum Pharmaceuticals, Inc. (-16.47%), less than Ligand Pharmaceuticals Incorporated (4.21%), less than ADMA Biologics, Inc. (61.78%), greater than Praxis Precision Medicines, Inc. (-60.07%), less than ACADIA Pharmaceuticals Inc. (30.67%), greater than Soleno Therapeutics, Inc. (-25.88%), greater than Dyne Therapeutics, Inc. (-64.12%), greater than Arcutis Biotherapeutics, Inc. (-29.69%), greater than Viking Therapeutics, Inc. (-29.35%), greater than Crinetics Pharmaceuticals, Inc. (-35.09%),
| Company | ROE | Market cap |
|---|---|---|
| -16.47% | $3.53B | |
| 4.21% | $3.71B | |
| 61.78% | $4.79B | |
| -60.07% | $4.02B | |
| 30.67% | $4.49B | |
| -25.88% | $2.83B | |
| -64.12% | $2.95B | |
| -29.69% | $3.82B | |
| -29.35% | $4.36B | |
| -35.09% | $4.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Belite Bio, Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Belite Bio, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Belite Bio, Inc's ROE?
How is the ROE calculated for Belite Bio, Inc (BLTE)?
What is the highest ROE for Belite Bio, Inc (BLTE)?
What is the 3-year average ROE for Belite Bio, Inc (BLTE)?
What is the 5-year average ROE for Belite Bio, Inc (BLTE)?
How does the current ROE for Belite Bio, Inc (BLTE) compare to its historical average?